CPT1C
Basic information
Region (hg38): 19:49690898-49713731
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 73 (Limited), mode of inheritance: AD
- hereditary spastic paraplegia 73 (Supportive), mode of inheritance: AD
- hereditary spastic paraplegia 73 (Strong), mode of inheritance: AD
- hereditary spastic paraplegia (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 73, autosomal dominant | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 25751282 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary spastic paraplegia 73 (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPT1C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 76 | 89 | ||||
missense | 130 | 12 | 145 | |||
nonsense | 6 | |||||
start loss | 1 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 6 | 12 | 1 | 19 | ||
non coding | 26 | 33 | ||||
Total | 6 | 5 | 140 | 114 | 16 |
Highest pathogenic variant AF is 0.0000131
Variants in CPT1C
This is a list of pathogenic ClinVar variants found in the CPT1C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-49692254-T-G | Hereditary spastic paraplegia 73 | Likely pathogenic (Aug 18, 2020) | ||
19-49692273-C-T | Hereditary spastic paraplegia 73 | Likely benign (Sep 03, 2020) | ||
19-49692278-G-A | Hereditary spastic paraplegia 73 | Uncertain significance (Oct 17, 2023) | ||
19-49692285-A-T | Hereditary spastic paraplegia 73 | Likely benign (Jun 16, 2022) | ||
19-49692291-G-A | Hereditary spastic paraplegia 73 | Likely benign (Mar 23, 2022) | ||
19-49692299-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
19-49692303-C-A | Hereditary spastic paraplegia 73 | Uncertain significance (Oct 13, 2023) | ||
19-49692307-G-A | Hereditary spastic paraplegia 73 • not specified | Uncertain significance (May 02, 2024) | ||
19-49692308-C-T | Hereditary spastic paraplegia 73 | Uncertain significance (Sep 23, 2022) | ||
19-49692322-A-G | Hereditary spastic paraplegia 73 | Uncertain significance (Jul 17, 2023) | ||
19-49692359-T-G | Hereditary spastic paraplegia 73 | Uncertain significance (Sep 01, 2022) | ||
19-49692361-C-T | Hereditary spastic paraplegia 73 | Pathogenic (Mar 09, 2015) | ||
19-49692362-G-A | Hereditary spastic paraplegia 73 | Uncertain significance (Nov 03, 2022) | ||
19-49692363-C-T | Hereditary spastic paraplegia 73 | Likely benign (Jan 29, 2024) | ||
19-49692374-G-C | Hereditary spastic paraplegia 73 | Uncertain significance (Oct 06, 2023) | ||
19-49692391-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
19-49692403-G-A | Hereditary spastic paraplegia 73 | Benign (May 15, 2023) | ||
19-49692412-C-T | Hereditary spastic paraplegia 73 | Likely benign (Jan 05, 2024) | ||
19-49697330-A-T | Hereditary spastic paraplegia 73 | Uncertain significance (Sep 26, 2021) | ||
19-49697340-C-T | Hereditary spastic paraplegia 73 | Likely benign (Sep 22, 2023) | ||
19-49697341-G-A | Hereditary spastic paraplegia 73 | Uncertain significance (Aug 04, 2021) | ||
19-49697364-C-T | Hereditary spastic paraplegia 73 | Likely benign (Jan 13, 2023) | ||
19-49697380-T-G | Hereditary spastic paraplegia 73 • not specified | Uncertain significance (May 24, 2023) | ||
19-49697384-G-A | Hereditary spastic paraplegia 73 • not specified | Uncertain significance (Oct 14, 2023) | ||
19-49697387-C-T | Hereditary spastic paraplegia 73 | Uncertain significance (Oct 08, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CPT1C | protein_coding | protein_coding | ENST00000392518 | 18 | 22834 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.19e-9 | 1.00 | 125687 | 0 | 61 | 125748 | 0.000243 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.31 | 419 | 502 | 0.835 | 0.0000324 | 5177 |
Missense in Polyphen | 165 | 197.12 | 0.83705 | 1990 | ||
Synonymous | -0.690 | 233 | 220 | 1.06 | 0.0000149 | 1662 |
Loss of Function | 3.20 | 22 | 45.2 | 0.486 | 0.00000246 | 438 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000912 | 0.0000905 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.000247 | 0.000231 |
European (Non-Finnish) | 0.000277 | 0.000273 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000460 | 0.000457 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in lipid metabolic process. {ECO:0000269|PubMed:25751282}.;
- Pathway
- Adipocytokine signaling pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);AMP-activated Protein Kinase (AMPK) Signaling;PPAR signaling pathway;mitochondrial L-carnitine shuttle;FOXA2 and FOXA3 transcription factor networks
(Consensus)
Intolerance Scores
- loftool
- 0.0663
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.78
Haploinsufficiency Scores
- pHI
- 0.204
- hipred
- Y
- hipred_score
- 0.674
- ghis
- 0.570
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.798
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cpt1c
- Phenotype
- growth/size/body region phenotype; muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); neoplasm; hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- fatty acid beta-oxidation;carnitine metabolic process;long-chain fatty acid transport;regulation of postsynaptic membrane neurotransmitter receptor levels
- Cellular component
- mitochondrion;mitochondrial outer membrane;endoplasmic reticulum;cell junction;integral component of endoplasmic reticulum membrane;axon;dendrite;AMPA glutamate receptor complex;postsynapse;glutamatergic synapse
- Molecular function
- carnitine O-palmitoyltransferase activity;protein binding